Norman: The Moderate Rise and Tragic Fall of a New York Fixer (5/10) Movie Review

richard Gere_CWEB

Norman: The Moderate Rise and Tragic Fall of a New York Fixer (5/10)

by Tony Medley

Runtime 118 minutes.

OK for children.

Written and directed by Joseph Cedar, this pictures Norman Oppenheimer (Richard Gere) as a New York “fixer.” At the beginning of the film, he insinuates himself into a relationship with Micha Eshel (Lior Ashkenazi), who is an up-and-coming Israeli politician. When Micha eventually becomes the prime minister of Israel, Norman finds himself in the middle of a maelstrom.

In telling the story of Norman, Cedar is telling a tale of a Court Jew, a narrative that can be traced back to the Old Testament. Cedar describes it as follows, “a Jew meets a man who eventually becomes a man with power, but he meets him at a point where his resistance is very low. He offers the man a gift or a favor, and when the man ends up being in power, he brings the Jew into his courts. The Jew rises to become a senior consultant until he becomes subject to a lot of antagonism, at which point the duke or king, or whoever he is, has no problem getting rid of him. He’s a liability and it’s easy to get rid of the Jew.”

Samples abound, Shylock in “the Merchant of Venice,” Fagan in “Oliver Twist” and Leopold Bloom in “Ulysses.” My question is, why pick a gentile to play a Jew? There are lots of Jewish actors who could have done this role. Dustin Hoffman comes to mind, and he’s the right age, too. Nothing against Gere’s performance; it’s just that one would think that, since this is an ethnocentric movie, one would get an actor who is the right ethnicity.

Except for its length, the film is exceptionally well done. Gere gives one of his better performances and Ashkenazi shines as the man who becomes prime minister. Also helping out are Michael Sheen and Steve Buscemi. But this is Gere’s film. What he needed was a good editor with sharp scissors and a director who had a better understanding of pace. As good as the film is, it was hard to stay awake throughout.

Tony Medley is an attorney, columnist, and MPAA-accredited film critic whose reviews and articles may be read in several newspapers and at,, Movie Review Query Engine (, and at He is the author of three books, UCLA Basketball:The Real Story, Sweaty Palms: The Neglected Art of Being Interviewed, the first book ever written on the interview for the interviewee and still in print after more than thirty years, having sold over a half million copies, and The Complete Idiot’s Guide to Bridge, which has sold over 100,000 copies. He is an American Contract Bridge League Silver Life Master and an ACBL accredited director.

Photo Credit:

Follow us on Google news for more updates and News


This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer